A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial.

Bafadhel M., Barnes N., Bourke SC., Compton C., Criner GJ., Dransfield MT., Halpin DMG., Han MK., Hartley B., Jones CE., Lange P., Lettis S., Lipson DA., Lomas DA., Martin N., Martinez FJ., Wise R., Singh D.

DOI

10.1183/13993003.04522-2020

Type

Journal article

Journal

Eur Respir J

Publication Date

12/08/2021

Permalink Original publication